Dianthus Therapeutics (DNTH) Treasury Shares (2017 - 2022)
Dianthus Therapeutics (DNTH) recorded quarterly Treasury Shares of $16084.0 in Q4 2022, down 94.45% quarter-over-quarter from $289918.0 in Q4 2021, and down 94.45% on a YoY basis from $289918.0 in Q4 2021.
Dianthus Therapeutics (DNTH) Treasury Shares (2017 - 2022) Analysis & Trends
Dianthus Therapeutics' Treasury Shares history runs 6 years deep, the most recent figure standing at $16084.0 for Q4 2022.
- In Q4 2022, Treasury Shares fell 94.45% year-over-year to $16084.0; the TTM figure through Dec 2022 stood at $16084.0 (down 94.45% YoY), while the FY2022 annual figure was $16084.0, down 94.45% from the prior year.
- Treasury Shares was $16084.0 for Q4 2022 at Dianthus Therapeutics, down from $289918.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.0 million in Q4 2018 to a low of $8466.0 in Q4 2020.
- Historically, Treasury Shares has averaged $345040.4 across 5 years, with a median of $289918.0 in 2021.
- The sharpest annual moves came in 2020 and 2021: Treasury Shares sank 95.88% in 2020, then surged 3324.5% in 2021.
- A 5-year view of Treasury Shares shows it stood at $1.0 million in 2018, then slumped by 79.88% to $205722.0 in 2019, then tumbled by 95.88% to $8466.0 in 2020, then soared by 3324.5% to $289918.0 in 2021, then sank by 94.45% to $16084.0 in 2022.
- The last three Treasury Shares figures came in at $16084.0 (Q4 2022), $289918.0 (Q4 2021), and $8466.0 (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 16,084.00 |
| Dec 31, 2022 | 16,084.00 |
| Dec 31, 2021 | 289,918.00 |
| Dec 31, 2021 | 289,918.00 |
| Dec 31, 2020 | 8,466.00 |
| Dec 31, 2020 | 8,466.00 |
| Dec 31, 2019 | 205,722.00 |
| Dec 31, 2019 | 205,722.00 |
| Dec 31, 2018 | 1.02 Mn |
| Dec 31, 2018 | 1.02 Mn |
| Sep 30, 2018 | 398,777.00 |
| Sep 30, 2018 | 398,777.00 |
| Jun 30, 2018 | 473,795.00 |
| Jun 30, 2018 | 473,795.00 |
| Dec 31, 2017 | 626,376.00 |
| Dec 31, 2017 | 626,376.00 |